Riskpilot← Back to searchSign inGet full accessiLab Medical AB
ABActiveOrg 5592746811Järnbrotts Prästväg 2Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 20202 employees
Revenue 2024
SEK 8,2M
+51% vs 2023
EBITDA margin
-18.7%
+61% vs 2023
Equity ratio
31.6%
Financial strength
Net profit 2024
SEK -3,7M
+13% vs 2023
| Revenue | SEK 8,2M | +51% |
| EBITDA | SEK -1,5M | +61% |
| Net profit | SEK -3,7M | +13% |
| Total assets | SEK 6,2M | -29% |
| Equity | SEK 2M | -65% |
| Employees | 2 | — |
Legal name
iLab Medical AB
Org number
5592746811
Legal form
Aktiebolag
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
2 oktober 2020
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Pålsson, Simon Henry Styrelsen ska bestå av 3 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Bolaget ska bedriva medicinsk laboratorieverksamhet.
Address
Järnbrotts Prästväg 2
Email
info@i-lab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 44 539 | 8 796 | 5 454 | 8 233 |
| Staff expenses | — | −2 625 | −2 898 | −1 346 |
| EBITDA | 20 152 | −1 121 | −3 931 | −1 541 |
| Depreciation & amort. | −1 152 | −2 053 | −2 057 | −2 090 |
| EBIT | 19 000 | −3 174 | −5 989 | −3 630 |
| Net financials | −6 | −8 | −11 | −63 |
| Profit before tax | 12 265 | 1 771 | −4 224 | −3 694 |
| Tax | −2 633 | −5 | — | — |
| Net profit | 9 632 | 1 766 | −4 224 | −3 694 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 22 028 | 12 397 | 8 669 | 6 195 |
| Equity | 11 057 | 9 823 | 5 599 | 1 955 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 4 243 | 798 | 3 070 | 4 240 |
| Total debt | 4 243 | 798 | 3 070 | 4 240 |
EBITDA margin
-18.7%
This company
15.8%
Market median
-218% vs market
20212024
Equity ratio
31.6%
This company
38.2%
Market median
+17% vs market
20212024
Return on equity
-188.9%
This company
18.4%
Market median
-1127% vs market
20212024
Net profit margin
-44.9%
This company
8.1%
Market median
-654% vs market
20212024
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20212024
Debt / equity
2.17×
This company
0.62×
Market median
-250% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SH Chief Auditor | Chief Auditor | 2025 |
| Former (3) | ||
MS Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
HE Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
DR Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Chairman | 2021 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2021 | |
| Former (6) | ||
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of iLab Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mayah Satarvandi | Chief Executive Officer | 0 companies |
| Hans Erik Christian Bieth | Chief Executive Officer | 0 companies |
| Stefan Hugo Kylebäck | Chief Auditor | 0 companies |
| Dusan Raicevic | Chief Executive Officer | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| John Robin Svedung | Board of Directors | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Per Axel Svensson | Deputy Board Member | 0 companies |
| Simon Henry Pålsson | Chairman | 0 companies |
| Siri Maria Pålsson | Deputy Board Member | 0 companies |
| Mohamed Ridha Ben Ahmed Hadfi | Board of Directors | 0 companies |
| Huaqing Li | Chairman | 0 companies |
| Emma Müntzing | Board of Directors | 0 companies |